2148 related articles for article (PubMed ID: 11437088)
1. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
[TBL] [Abstract][Full Text] [Related]
2. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 2: Preliminary UK estimates of prevalent injection-related hepatitis C carriers, and derivation of progression rates to liver cirrhosis by gender and age at hepatitis C virus infection.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):267-77; discussion 279-85. PubMed ID: 11437089
[TBL] [Abstract][Full Text] [Related]
3. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
4. Anonymous HIV surveillance with risk-factor elicitation: at Perth (for men) and Cornton Vale (for women) prisons in Scotland.
Gore SM; Bird AG; Burns S; Ross AJ; Goldberg D
Int J STD AIDS; 1997 Mar; 8(3):166-75. PubMed ID: 9089027
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and incidence of hepatitis C in injecting drug users attending genitourinary medicine clinics.
Balogun MA; Murphy N; Nunn S; Grant A; Andrews NJ; Teo CG; Ramsay ME; Parry JV
Epidemiol Infect; 2009 Jul; 137(7):980-7. PubMed ID: 19102796
[TBL] [Abstract][Full Text] [Related]
6. Pilot study to estimate survivors to 1995 of 1983-1984 prevalent hepatitis C infections in Lothian patients who tested positive or negative for hepatitis B surface antigen in 1983-1984.
Gore SM; Brettle RP; Burns SM; Lewis SC
J Infect; 1998 Sep; 37(2):159-65. PubMed ID: 9821091
[TBL] [Abstract][Full Text] [Related]
7. Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973-2030.
Meijerink H; White RA; Løvlie A; de Blasio BF; Dalgard O; Amundsen EJ; Melum E; Kløvstad H
BMC Infect Dis; 2017 Aug; 17(1):541. PubMed ID: 28774261
[TBL] [Abstract][Full Text] [Related]
8. Performance and image enhancing drug injectors' access to needle syringe programs: Responding to a public policy dilemma.
van Beek I; Chronister KJ
Int J Drug Policy; 2015 Sep; 26(9):868-74. PubMed ID: 26118797
[TBL] [Abstract][Full Text] [Related]
9. High Prevalence and Incidence of HIV and HCV Among New Injecting Drug Users With a Large Proportion of Migrants--Is Prevention Failing?
Folch C; Casabona J; Espelt A; Majó X; Meroño M; Gonzalez V; Wiessing L; Colom J; Brugal MT;
Subst Use Misuse; 2016 Jan; 51(2):250-60. PubMed ID: 26820260
[TBL] [Abstract][Full Text] [Related]
10. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?
Taylor A; Goldberg D; Hutchinson S; Cameron S; Gore SM; McMenamin J; Green S; Pithie A; Fox R
J Infect; 2000 Mar; 40(2):176-83. PubMed ID: 10841096
[TBL] [Abstract][Full Text] [Related]
12. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study.
Bellentani S; Pozzato G; Saccoccio G; Crovatto M; Crocè LS; Mazzoran L; Masutti F; Cristianini G; Tiribelli C
Gut; 1999 Jun; 44(6):874-80. PubMed ID: 10323892
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of testing for hepatitis C in former injecting drug users.
Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K
Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of hepatitis C: related hepatocellular carcinoma in Cameroon.
Andoulo FA; Noah DN; Djapa R; Kowo M; Talla P; Medjo EH; Djomkam IK; Nonga BN; Njoya O; Ndam EC
Pan Afr Med J; 2014; 19():379. PubMed ID: 25977742
[TBL] [Abstract][Full Text] [Related]
15. Modelling and calibration of the hepatitis C epidemic in Australia.
Razali K; Amin J; Dore GJ; Law MG; HCV Projections Working Group
Stat Methods Med Res; 2009 Jun; 18(3):253-70. PubMed ID: 19036911
[TBL] [Abstract][Full Text] [Related]
16. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.
Allen EJ; Palmateer NE; Hutchinson SJ; Cameron S; Goldberg DJ; Taylor A
Int J Drug Policy; 2012 Sep; 23(5):346-52. PubMed ID: 22940142
[TBL] [Abstract][Full Text] [Related]
17. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001.
Law MG; Dore GJ; Bath N; Thompson S; Crofts N; Dolan K; Giles W; Gow P; Kaldor J; Loveday S; Powell E; Spencer J; Wodak A
Int J Epidemiol; 2003 Oct; 32(5):717-24. PubMed ID: 14559738
[TBL] [Abstract][Full Text] [Related]
18. HCV prevalence and risk behaviours among injectors of new psychoactive substances in a risk environment in Hungary-An expanding public health burden.
Tarján A; Dudás M; Wiessing L; Horváth G; Rusvai E; Tresó B; Csohán Á
Int J Drug Policy; 2017 Mar; 41():1-7. PubMed ID: 27984762
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: injecting careers, positivity and risk behaviour.
Rhodes T; Hunter GM; Stimson GV; Donoghoe MC; Noble A; Parry J; Chalmers C
Addiction; 1996 Oct; 91(10):1457-67. PubMed ID: 8917914
[TBL] [Abstract][Full Text] [Related]
20. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
